Rochussen takes the helm at Polar Capital
Gavin Rochussen has today taken up his role as chief executive of Polar Capital.
- News
-
- Analysis
-
- Investments
-
-
-
Top story
-
-
-
- Video
-
Polar Capital
-
-
Godber and Hamilton: How Polar Capital’s power duo find value
Polar Capital’s dynamic duo talk to Portfolio Adviser about the ongoing hunt for value, and taking turns on the ‘grunt work’.
-
Polar Capital laments third consecutive year of outflows
Polar Capital continued to feel the sting of outflows from four of its major strategies, resulting in its third consecutive year of net negative flows.
-
Godber prepares to sell after ‘unknown’ election consequences
Last week’s general election result will have plenty of consequences for investors despite fund managers’ claims it has not affected their allocation, Polar Capital’s George Godber has said.
-
Polar Capital bounces back with AUM rise
Polar Capital has said it is approaching the coming year “with confidence” after reporting a £2bn increase in assets under management.
-
Which asset manager is the next takeover target?
Last week’s £11bn merger between Standard Life and Aberdeen Asset Management was a game changer for the industry. Portfolio Adviser asked several wealth managers and analysts, who’s next?
-
Polar Capital names new CEO
Polar Capital Holdings has appointed Gavin Rochussen to its board to succeed Tim Woolley as chief executive.
-
Polar Capital confirms Hamilton/Godber launch as outflows bite
Polar Capital tempered the blow from reporting £763m in outflows with news on the former Miton duo’s debut fund at the asset manager.
-
Polar Capital eyes more manager raids
Polar Capital today said it has a “pipeline of further recruitment activity” in the works following on from the hiring of Miton’s George Godber and Georgina Hamilton.
-
HEAD-TO-HEAD: Polar Capital vs Man GLG
Fund Selector Asia compares two Japanese equity funds.
-
Three reasons to reconsider Europe – Polar Capital
Investors have voiced increasing concerns about growth in Europe, but according to Nick Davis, there remain three reasons to be positive.
-
HEAD-TO-HEAD: Axa Framlington Biotech vs Polar Capital Healthcare Opportunities
In this week’s Head-to-Head, Gavin Haynes, managing director at Whitechurch Securities, matches up two medical heavyweights – Axa Framlington Biotech and Polar Capital Healthcare Opportunities.